Worldâs Most Portable Molecular Diagnostics System Unveiled â MM1511
Cepheid and FIND have unveiled the GeneXpert & Omni, the worldâs most portable molecular diagnostics system enabling unprecedented access to accurate, fast and potentially lifesaving diagnosis for patients suspected of TB, HIV and Ebola in even the most remote areas of the world.
Modern Medicine â November 2015
Cepheid has announced that XpertÂŽ HCV Viral Load, a quantitative test that provides on-demand molecular testing for confirmation of infection and monitoring of Hepatitis C virus (HCV), has achieved CE-IVD status under the European Directive on In Vitro Diagnostic Medical Devices. The test runs on the Cepheid GeneXpertÂŽÂ System, the worldâs leading molecular diagnostic platform with over 8000 systems deployed globally in both developed and emerging market countries.
Modern Medicine â September 2015
Ilex APTIMA HPV Assay Provides Excellent Sensitivity, Helps Reduce False-positives â MM1508
The identification of human papillomavirus (HPV) as the aetiological agent for cervical cancer has had important implications for the future of cervical cancer screening and prevention strategies.
Modern Medicine â August 2015
Worldâs Most Portable Molecular Diagnostics System Unveiled â MM1508
Cepheid and FIND have unveiled the GeneXpert & Omni, the worldâs most portable molecular diagnostics system enabling unprecedented access to accurate, fast and potentially lifesaving diagnosis for patients suspected of TB, HIV and Ebola in even the most remote areas of the world.
Modern Medicine â August 2015
Cepheid has announced that Xpert HCV Viral Load, a quantitative test that provides on-demand molecular testing for confirmation of infection and monitoring of Hepatitis C virus (HCV), has achieved CE-IVD status under the European Directive on In Vitro Diagnostic Medical Devices. The test runs on the Cepheid GeneXpert System, the worldâs leading molecular diagnostic platform with over 8000 systems deployed globally in both developed and emerging market countries.
Modern Medicine â July 2015
Cepheid and FIND announced last month that XpertÂŽ HIV-1 Qual, a qualitative 90-minute molecular HIV test, has achieved CE-IVD status under the European Directive on In Vitro Diagnostic Medical Devices. The test runs on the Cepheid GeneXpertÂŽ System, the worldâs leading molecular diagnostic platform with over 8000 systems deployed globally in both developed and emerging market countries.
Modern Medicine â May 2015
Cepheidâs Xpert HIV-1 Viral Load Test Gets European Approval â MM1502
Quantitative test for rapid measurement of the HIV-1 Viral Load in plasma delivers individual results in about 90 minutes.
Modern Medicine â February 2015
